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Background/aim: Acinetobacter baumannii is one of the most commonly encountered microorganisms in nosocomial infections.
It is thought that strains found in the environment can be a source for contamination of patients by Acinetobacter strains that are
resistant to environmental conditions. This study was carried out to compare Acinetobacter strains isolated from a variety of nonviable
environments and from patients in intensive care units (ICUs), and to explore whether environmental areas may be a source for bacterial
contamination.
Materials and methods: We studied A. baumannii strains isolated from ICU patients. When A. baumannii was isolated from the
clinical sample of a patient, swab samples were collected from various areas in the ICU. VITEK 2 (bioMérieux, France) was used for the
identification of A. baumannii strains and for antibiotic sensitivity tests. DNA fingerprinting analysis was performed with the repetitive
sequence-based polymerase chain reaction (rep-PCR) method using a DiversiLab device (bioMérieux).
Results: During the study, a total of 100 A. baumannii strains including 92 samples from 61 patients and 8 samples from the environment
were isolated. All of the isolated strains were found to have multiresistance to antibiotics. DNA fingerprinting results showed that 7 of
the 8 strains isolated from the environment were identical to many strains isolated from the patients. The greatest similarity between
samples was found for 1 A. baumannii strain isolated from a computer keyboard, which was identical to the bacterium isolated from 17
other samples.
Conclusion: A high level of similarity was found between strains isolated from the environment and patients, suggesting deficiencies in
implementation of infection control measures.
Key words: Acinetobacter baumannii, source, rep-PCR, nosocomial infection

1. Introduction
Acinetobacter is one of the major causative agents of
nosocomial infections, which are resistant to multiple
drugs and are difficult to treat. In fact, Acinetobacter
species are bacteria that have low virulence. However,
they are identified as important opportunistic pathogens
among patients, particularly in those with impaired
functioning of normal host defense mechanisms (1).
Specifically, these are the most prevalent infectious
agents encountered in intensive care units (ICUs) all over
the world (2,3). The most important factors that lead to
frequent identification of Acinetobacter spp. as causative
agents in nosocomial infections include their resistance to
external conditions, long-term viability in environmental
areas, and their spread among patients (4). A. baumannii
spp. often colonize the skin and lower respiratory tracts of
hospitalized patients, and they are isolated from sputum,
* Correspondence: yaseminzer@hotmail.com

blood, urine, and fecal samples of the patients (5). While
Acinetobacter species are commonly found in water and
soil, they can also reside in frozen foods, clothes, patient
beds, and ventilator circuits and on many other materials
and surfaces in the hospital environment (6,7). As part
of infection control measures, close-contact isolation is
recommended when a multiresistant Acinetobacter strain
is isolated from a patient. This is a preemptive procedure
to prevent transmission from one patient to another.
Implementation of appropriate disinfection practices in
the surrounding areas is the most important protective
method. However, the failure to prevent Acinetobacter
infections, the occurrence of outbreaks in many centers,
and the fact that Acinetobacter strains continue to be
a major cause of mortality and morbidity among ICU
patients suggest that there are still some deficiencies in
implementation.
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This study was performed with the aim of investigating
the DNA-clonal relatedness of the Acinetobacter strains
isolated from various inanimate areas in the ICU and
strains isolated from ICU patients hospitalized in the
authors’ hospital and of evaluating the extent to which
environmental areas represent a source for bacterial
contamination.
2. Materials and methods
This study was carried out on A. baumannii strains isolated
from various clinical samples of patients hospitalized in
the internal ICU of the Gaziantep University Faculty of
Medicine Hospital from January 2010 to June 2011. Strains
included in the study were isolated from tracheal aspirate,
blood, catheter, urine, and cerebrospinal fluid (CSF)
samples. Care was taken to ensure that transportation
of the samples to the laboratory occurred inside suitable
containers and/or transportation media. Samples from
blood cultures were delivered to the laboratory after being
collecting in BacT-Alert (bioMérieux, France) automated
blood culture bottles. Apart from blood cultures, suitable
samples were inoculated into 5% sheep blood agar and eosin
methylene blue agar and were incubated for 24–48 h at 35
°C under aerobic conditions. Subcultures were obtained in
the aforementioned growth media after observing growth
signals in blood culture samples. Isolated bacteria were
identified at the species level using conventional methods
and the VITEK 2 automated identification system
(bioMérieux). Surface swab samples were collected from
inanimate surfaces in the ICU (e.g., patient beds, patient
blankets, aspiration devices, cabinets, lavatory, faucets,
ventilator circuits, air conditioners, nurses’ desks, curtains,
and door handles) when A. baumannii was isolated from
a sample obtained from an ICU patient. Cotton swabs
moistened with sterile saline were used when collecting
samples from surrounding areas in order to eliminate the
inhibitory effect of fatty acids from the cotton swabs. Since
environmental samples were obtained after observing
the growth of A. baumannii in a sample, environmental
samples were obtained after a mean of 24 h. The same
procedure used for clinical samples was followed for
growth and identification of these samples.
Antibiotics susceptibility testing for the isolated
bacteria was performed using VITEK 2.
Isolates were stored at –80° C until the time of DNA
sequence analysis.
2.1. Rep-PCR
The similarity of DNA patterns of isolates was determined
using a DiversiLab device (bioMérieux), which utilized an
automated repetitive sequence-based polymerase chain
reaction (rep-PCR) method.

644

2.1.1. PCR Steps
1) DNA extraction was manually performed from pure A.
baumannii cultures.
2) DNA amplification with rep-PCR: rep-PCR was
performed using a commercial master mix, a PCR buffer,
a primer mix, and Taq polymerase. Amplification was
completed according to the recommended procedure
for 35 cycles. Steps for each cycle are shown in Table 1.
3) Automated microfluidic electrophoresis was performed
using a bioanalyzer.
4) Web-based interpretation and evaluation:
Analyses were performed using DiversiLab software
(version 2.1.66), and Pearson’s correlation coefficient was
used to determine the distance between the matrices. The
unweighted pair group method with arithmetic mean
(UPGMA) was used to generate the dendrograms.
A dendrogram showing the automatic reading of
computer-generated DNA fingerprints, a similarity matrix
that displays and color codes similar DNA sequences, and
a dot chart that plots the similarity between strains were
used to interpret the data.
In the similarity matrix, red indicates 100%–95%
similarity, orange 95%–90% similarity, blue 90%–80%
similarity, pink 80%–70% similarity, and gray 70%–0%
similarity. When 100%–95% similarity was found between
strains, those strains were considered identical.
This study was conducted after obtaining approval
from the local ethics committee and was supported by the
Gaziantep University Scientific Research Projects Unit.
3. Results
During the study period, 100 A. baumannii strains were
isolated, including 92 from patients and 8 from the ICU
environment. Clinical samples belonged to 61 patients.
A total of 54 strains were isolated from different clinical
samples of 23 patients. In the patient cohort, 21 (34%)
patients were female and 40 (66%) were male. The age
range of the patients was 16–86 years (58.0 ± 17.7).
The breakdown of strains isolated from patients and
sampling sites is shown in Table 2.
Table 1. DNA amplification cycle.
Step

Temp (°C)

Time (s)

Initial denaturation

94

120

Denaturation

94

30

Annealing

45

30

Extension

70

90

Final extension

70

90

Hold

4

-
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Table 2. The distribution of A. baumannii isolates according to
the isolated clinical samples.

Table 3. The distribution of A. baumannii strains isolated from
environmental samples.

Sample type

Sample number

Percent (%)

Area

Isolates

Tracheal aspirate

48

52

Bed

1

Blood

26

28

Ventilator screen

1

Urine

9

10

In front of door curtain in patient room

1

Catheter

6

7

Outer cover of dustbin

1

Probe tap

2

2

Staff uniform

2

CSF

1

1

Faucet

1

Total

92

100

Computer keyboard

1

Total

8

A total of 400 swab samples were obtained from
inanimate surfaces of the patients’ environment. A.
baumannii was isolated from 8 of these samples. Although
this was a prospective study, environmental samples were
obtained approximately 24 h after the identification of the
bacteria that had grown in the patients’ clinical samples,
since there was no way to predict which patients would
show growth of A. baumannii. The breakdown of strains
isolated from inanimate areas is shown in Table 3.
Results of antibiotic susceptibility for study strains are
shown in Table 4.
Colistin, which showed efficacy against all strains
except one, was found to be the most effective antimicrobial
for all strains tested. Other effective antimicrobials were
tobramycin (94%) and tigecycline (79%). A high level
of resistance was found against carbapenems (98% for
imipenem, 99% for meropenem). The effectiveness of betalactam antibiotics was found to be very low, and while only
one isolate (1%) was susceptible to cefepime, none of the
isolates showed susceptibility to ceftriaxone, ceftazidime,
or piperacillin. Moreover, there were not any isolates
showing susceptibility to antimicrobial combinations

containing beta-lactamase inhibitors (e.g., piperacillin/
tazobactam and ampicillin/sulbactam). All strains isolated
from environmental areas, except 1, showed resistance to
most of the antibiotics tested, and 1 strain (isolated from
a faucet) was found to be susceptible to all antibiotics. The
antibiotic susceptibility of environmental isolates was as
follows: colistin, 100% (8 isolates); tobramycin, 100% (8
isolates); tigecycline, 75% (6 isolates); amikacin, 50% (4
isolates); gentamicin, 25% (2 isolates); and ceftriaxone,
ciprofloxacin, imipenem, trimethoprim/sulfamethoxazole,
ampicillin/sulbactam, and cefoperazone/sulbactam, 12.5%
(1 isolate each).
DNA fingerprinting analyses of the isolates showed
that 7 of the 8 strains isolated from the environment were
identical to many of the strains isolated from the patients.
The greatest sample similarity was found for one A.
baumannii strain isolated from a computer keyboard,
which was identical to the bacterium isolated from
another 17 samples. The similarity matrix comparing
strains isolated from patients and strains isolated from

Gentamicin

Tobramycin

Tigecycline

TZP4

Ceftazidime

SFP3

Cefepime

SAM2

Levofloxacin

Meropenem

SXT1

Imipenem

Amikacin

Colistin

Ciprofloxacin

Antibiotics

Ceftriaxone

Table 4. Antimicrobial susceptibility results of A. baumannii strains.

Susceptible number
(%)

-

1
(1)

91
(99)

37
(40)

2
(2)

1
(1)

1
(1)

1
(1)

-

1
(1)

9
(10)

-

-

72
(78)

86
(94)

20
(22)

Resistant number
(%)

92
(100)

91
(99)

1
(1)

55
(60)

90
(98)

91
(99)

91
(99)

91
(99)

92
(100)

91
(99)

83 (
90)

92
(100)

92
(100)

20
(22)

6 (6)

72
(78)

SXT¹: Trimethoprim/sulfamethoxazole, SAM2: ampicillin/sulbactam, SFP3: cefoperazone/sulbactam, TZP4: piperacillin/tazobactam.
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Figure. The similarity matrix of A. baumannii strains in hospital and environment samples.

surrounding areas is shown in the Figure (strains isolated
from environmental sources are shown in green, and
strains isolated from clinical samples are shown in blue).
The similarity between isolated strains is shown in
Table 5.

As a result of the comparison of 54 samples obtained
from 23 patients, bands with >95% similarity were
observed in only one patient (blood culture and tracheal
aspiration samples); similarity in other samples was not at
the level to prove same clonal origin.

Table 5. The similarity between strains.
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Environment sample

Similarity

2 (Faucet)

No similarity was determined

19 (Staff uniform)

17, 18, 20, 21

32 (Staff uniform)

24, 25

37 (Ventilator screen)

34, 35, 36, 38, 39, 40, 41, 42, 43, 44

43 (Curtain)

34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 46

48 (Dustbin-outer cover)

47, 49

74 (Keyboard)

64, 65, 66, 67, 68, 69, 70, 73, 75, 76, 77, 78, 79, 80, 81, 82, 83

82 (Bed)

64, 65, 66, 67, 68, 69, 70, 73, 74, 75, 76, 77, 79, 80, 81, 83
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When the similarity between sample groups was
investigated, 3 clones were detected in the blood cultures.
Of those, 2 samples in clone 1, 3 samples in clone 2,
and 6 samples in clone 3 were found to be identical. Of
the tracheal aspirate samples, similarity was found only
between 2 samples. All other samples were found to be
different from each other.
4. Discussion
Acinetobacter strains are opportunistic pathogens that
are commonly found in soil and water, and their role
in hospital-acquired infections as the causative agent
has been increasing day by day (8). Multiresistant
Acinetobacter species emerge in hospitals, especially in
ICUs, and occasionally cause outbreaks. The widespread
use of antimicrobials in ICUs and the increased need for
invasive diagnostic and therapeutic methods lead to the
development of infections by resistant bacteria, primarily
Acinetobacter species (9,10). According to data from the
National Nosocomial Infections Surveillance System in
the United States, the incidence of nosocomial infections
caused by Acinetobacter spp. has increased substantially,
and while 1.4% of gram-negative nosocomial infections
were caused by Acinetobacter species in 1975, this rate had
increased to 6.2% in 2003 (11).
A. baumannii has been reported to be the most
common Acinetobacter species isolated from patients
and the hospital environment. Its tolerance of dryness
and its multidrug resistance contribute to the ability of A.
baumannii to cause hospital outbreaks (1). Acinetobacter
species can survive in humid environments, such as
ventilator devices at hospitals, and also in dry conditions
for extended periods. Additionally, they frequently
colonize the skin of both patients and hospital staff. These
areas are also important reservoirs for cross-contamination
of patients (11–15).
In this study, the DNA similarities of the strains
isolated from the environmental areas in the ICU and the
strains from clinical samples of patients were compared.
The isolates were not evaluated on the basis of the
causative agent or colonization. A single isolate from each
patient was included in the study as long as the clinical
sample was identical; when the strain was isolated from
a different clinical sample, that clinical sample was also
included in the study. During the study, 400 swab samples
were collected, and A. baumannii was isolated from 8 of
them. In their study, Ayan et al. (14) collected 154 samples
from the environmental areas of an ICU and did not
isolate A. baumannii from any of these samples. Since the
level of adherence to the disinfection procedures varies in
each hospital, these results were not surprising. However,
during the sampling procedure in our study, cotton swabs
used to collect the samples were soaked in sterile saline

to eliminate the inhibitory effect of fatty acids. This was
thought to increase the chance of successful isolation.
Strains isolated in our study were found to be multidrug
resistant. Additionally, all strains but one (a strain isolated
from a faucet) isolated from environmental samples were
multidrug resistant.
Carbapenem resistance was found in 98% of strains
isolated in this study. In previous studies conducted in the
authors’ hospital, Karsligil et al. (16) found carbapenem
resistance at a rate of 9.6% in 2004, whereas it was 53.5% in
Özgür Akın et al.’s 2009 study (17); the significant increase
in the resistance rate is remarkable. It was reported that
carbapenem-resistant A. baumannii infections commonly
occur in many hospitals (4,18–20). In fact, variable rates
of antibiotic resistance in different hospitals are not
surprising. However, a striking increase was observed in
antimicrobial resistance as in the case for carbapenems.
Colistin was found to be the most effective antimicrobial
for all strains tested, and while resistance was observed
in only one of the strains, the others were susceptible.
Susceptibility rates to tobramycin and tigecycline were
94% and 79%, respectively.
Biotyping, antibiotyping, ribobiotyping, PCR-based
fingerprinting, and pulsed-field gel electrophoresis
(PFGE) of genomic DNA were used for exploring the
similarity between bacteria (14). PFGE is the gold
standard for bacterial discrimination. However, PCRbased fingerprinting methods have been increasingly used
in recent years. In this study, a similar test was used, and
the results were obtained by accessing a large database
through web-based software.
The fact that strains isolated from the environment
were identical to many of the patient samples suggested
that environmental areas in the ICU of the authors’ hospital
could be a significant source for contamination in the ICU.
In fact, when a multidrug-resistant A. baumannii strain
is isolated from a patient, procedures for close-contact
isolation are implemented in our ICU as part of infection
control practices. However, the similarity between the
strains isolated from the areas with no direct contact with
patients and strains isolated from the patients is surprising.
For instance, the strain isolated from a computer keyboard
on a nurse’s desk was similar to 17 other samples, and the
strain isolated from a curtain between patient beds was
similar to 12 clinical samples.
Another result that was surprising for us was that,
among 54 different clinical strains isolated from 23 patients,
similarity was found between tracheal aspirate and blood
culture samples isolated from 1 patient. Unlike the other 7
strains, an A. baumannii strain isolated from a wash basin had
a susceptible antibiotic profile, and its DNA sequence did not
show any similarity to other strains. This suggested that this
strain could be an Acinetobacter species found in water.
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Lowering infection-related mortality and morbidity
rates in ICUs is a multidisciplinary task. Active surveillance
practices should be implemented in ICUs in accordance with
infection control measures, and procedures for antibiotic use

should be tailored to individual resistance rates observed in
the units and areas monitored periodically that could be a
potential source for bacteria (the skin, nose, and throat of
healthcare professionals, environmental areas).
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